Generation 0 cells showed a trend toward a stronger G 1 delay in the short term, confirmed in all treatment groups, and increased delays/block in S and G 2 M in the long term, which may counteract the cell death expected after removal of gemcitabine.
← all excerpts
Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer.
1
—
—